STRS Ohio’s Damora Therapeutics DMRA Stock Holding History

STRS Ohio’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$272K	Buy	+12,800	New	+$362K	﹤0.01%	1498

Other funds holding DMRA

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

STRS Ohio's DMRA Position: Q3 2026 in Review

STRS Ohio opened a new position in Damora Therapeutics (DMRA) in Q3 2026: 12,800 shares worth $272K. The stake represents ﹤0.01% of the portfolio and ranks #1498 among its holdings.

13 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.

STRS Ohio held 12,800 shares of Damora Therapeutics worth $272K as of Q3 2026.
Damora Therapeutics was a new STRS Ohio position in Q3 2026.
Damora Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1498 holding.
13 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.